These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20535823)

  • 1. The identification of Parkinson's disease subtypes using cluster analysis: a systematic review.
    van Rooden SM; Heiser WJ; Kok JN; Verbaan D; van Hilten JJ; Marinus J
    Mov Disord; 2010 Jun; 25(8):969-78. PubMed ID: 20535823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease subtypes: lost in translation?
    Marras C; Lang A
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):409-15. PubMed ID: 22952329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical subtypes of Parkinson's disease.
    van Rooden SM; Colas F; Martínez-Martín P; Visser M; Verbaan D; Marinus J; Chaudhuri RK; Kok JN; van Hilten JJ
    Mov Disord; 2011 Jan; 26(1):51-8. PubMed ID: 21322019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity among patients with Parkinson's disease: cluster analysis and genetic association.
    Ma LY; Chan P; Gu ZQ; Li FF; Feng T
    J Neurol Sci; 2015 Apr; 351(1-2):41-45. PubMed ID: 25732803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling cognitive and neuropsychiatric heterogeneity in Parkinson's disease.
    van Balkom TD; Vriend C; Berendse HW; Foncke EM; van der Werf YD; van den Heuvel OA; Klein M
    Parkinsonism Relat Disord; 2016 Jul; 28():130-6. PubMed ID: 27215393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.
    Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB
    JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease.
    Erro R; Picillo M; Vitale C; Palladino R; Amboni M; Moccia M; Pellecchia MT; Barone P
    Parkinsonism Relat Disord; 2016 Jul; 28():137-40. PubMed ID: 27158121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtypes of Parkinson's disease: state of the field and future directions.
    Marras C
    Curr Opin Neurol; 2015 Aug; 28(4):382-6. PubMed ID: 26110797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor subtype changes in early Parkinson's disease.
    Eisinger RS; Hess CW; Martinez-Ramirez D; Almeida L; Foote KD; Okun MS; Gunduz A
    Parkinsonism Relat Disord; 2017 Oct; 43():67-72. PubMed ID: 28754232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort.
    Lawton M; Baig F; Rolinski M; Ruffman C; Nithi K; May MT; Ben-Shlomo Y; Hu MT
    J Parkinsons Dis; 2015; 5(2):269-79. PubMed ID: 26405788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying and predicting Parkinson's disease subtypes through trajectory clustering via bipartite networks.
    Krishnagopal S; Coelln RV; Shulman LM; Girvan M
    PLoS One; 2020; 15(6):e0233296. PubMed ID: 32555729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical REM sleep behavior disorder and motor subtypes in Parkinson's disease: a questionnaire-based study.
    Aygun D; Turkel Y; Onar MK; Sunter T
    Clin Neurol Neurosurg; 2014 Apr; 119():54-8. PubMed ID: 24635926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmotor Subtyping in Parkinson's Disease.
    Sauerbier A; Rosa-Grilo M; Qamar MA; Chaudhuri KR
    Int Rev Neurobiol; 2017; 133():447-478. PubMed ID: 28802928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of data-driven Parkinson's disease subtypes for clinical research.
    Mestre TA; Eberly S; Tanner C; Grimes D; Lang AE; Oakes D; Marras C
    Parkinsonism Relat Disord; 2018 Nov; 56():102-106. PubMed ID: 30056038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.
    Mestre TA; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Marinus J; Mollenhauer B; Postuma R; Rajalingam R; Rodríguez-Violante M; Simuni T; Surmeier DJ; Weintraub D; McDermott MP; Lawton M; Marras C
    J Parkinsons Dis; 2021; 11(2):395-404. PubMed ID: 33682731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of cluster results for different types of time adjustments in complex disease research.
    Colas F; Meulenbelt I; Houwing-Duistermaat JJ; Kloppenburg M; Watt I; van Rooden SM; Visser M; Marinus J; van Hilten JJ; Slagboom P; Kok JN
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():4601-4. PubMed ID: 19163741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between motor subtypes and psychopathology in Parkinson's disease.
    Reijnders JS; Ehrt U; Lousberg R; Aarsland D; Leentjens AF
    Parkinsonism Relat Disord; 2009 Jun; 15(5):379-82. PubMed ID: 18977165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmotor features of Parkinson's disease subtypes.
    Marras C; Chaudhuri KR
    Mov Disord; 2016 Aug; 31(8):1095-102. PubMed ID: 26861861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
    Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Tanner C; Marek K;
    Parkinsonism Relat Disord; 2016 Jul; 28():62-7. PubMed ID: 27132498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.